Manufacturer record
Vivek Pharmachem (India) Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
38 batches manufactured by Vivek Pharmachem (India) Ltd (Rajasthan) were declared Not of Standard Quality between January 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
38 records linked to Vivek Pharmachem (India) Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
38Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
38
NSQ batches since 2019
17
Products affected
Dissolution
Most common failure
Jul 2026
Latest alert
Flagged batches per year
2019 · 22020 · 12021 · 52022 · 82023 · 52024 · 32025 · 82026 · 6
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Paediatric Syrup IP 60 ml | PCS25194Mfg 2025-09 · Exp 2027-08 | The sample does not conform to IP standards. It fails the test Microbial Examination of Non- Sterile Product as per IP, as specified in the Laboratory protocol.Microbial limits | DTL, TVPMState lab | Jul 2026 |
| Paracetamol Tablets I.P 650 mg | PCT25058Mfg 2025-04 · Exp 2027-03 | Test for DissolutionDissolution | RDTL, Hubli, KarnatakaState lab | Jun 2026 |
| Ciprofloxacin Tablets IP 500mg | CPT25066Mfg 2025-06 · Exp 2028-05 | The sample does not conform to IP, in Respect of Dissolution.Dissolution | DTL LucknowState lab | Jun 2026 |
| Ranitidine Hydrochloride Tablets IP 150mg | RDT24029Mfg 2024-06 · Exp 2026-05 | DescriptionDescription | DTL, KonniState lab | Mar 2026 |
| Paracetamol Tablets IP 650 MG | PCT25046Mfg 2025-04 · Exp 2027-03 | The sample does not conform to I.P. w.r.t. the tests for Dissolution.Dissolution | SDTL, AssamState lab | Feb 2026 |
| Paracetamol Tablets IP 650mg | PCT25094Mfg 2025-05 · Exp 2027-04 | The sample has been declared as Not of Standard Quality as it does not conform to IP standards with respect to Test for Dissolution only.Dissolution | KarnatakaState lab | Jan 2026 |
| Paracetamol Tablets IP 650 mg | PCT25093Mfg 2025-05 · Exp 2027-04 | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab | Nov 2025 |
| Paracetamol Tablets IP 650mg, | PCT25092Mfg 2025-05 · Exp 2027-04 | Test for Dissolution of TabletsDissolution | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Doxycycline Capsules IP 100mg | DXC24014Mfg 2024-06 · Exp 2027-05 | Test for Uniformity of Weight of CapsulesUniformity of weight/content | DTL, JaipurState lab | Oct 2025 |
| Ciprofloxacin Hydrochloride Tablets IP 250mg | CPT24039Mfg 2024-05 · Exp 2026-04 | Test for Dissolution.Dissolution | KarnatakaState lab | Jul 2025 |
| Paracetamol Tablets IP 500mg | PCTJ23058Mfg 2023-11 · Exp 2025-10 | DescriptionDescription | State Lab KarnatakaState lab | Jun 2025 |
| Ciprofloxacin Hydrochloride Tablets IP 250 mg. | CPT24046Mfg 2024-07 · Exp 2026-06 | DissolutionDissolution | State Lab KarnatakaState lab | Jun 2025 |
| Paracetamol Tablets IP 650mg | PCT24034Mfg 2024-02 · Exp 2026-01 | The sample has been declared as not of Standard Quality as it does not conform to IP standards with respect to Test for Dissolution and DescriptionDissolution | �KarnatakaState lab | May 2025 |
| Paracetamol Tablets IP 650 mg | PCT24034Mfg 2024-02 · Exp 2026-01 | Test for Dissolution? and ?DescriptionDissolution | State Lab KarnatakaState lab | Apr 2025 |
| Cefotaxime InjectionIP500mg | CTI2308 1Mfg 2023-08 · Exp 2025-01 | The sample does not conforms to I.P. with respect to the Test for 'Related Substances', 'Particulate matter' and 'Clarity of solution'Particulate matter | CDL KolkataCDSCO lab | May 2024 |
| Ciprofloxacin Tablets IP 500 mg | CPT 23022Mfg 2023-09 · Exp 2026-08 | It fails the test ?Dissolution? as per IPDissolution | SDTL ThiruvananthapuramState lab | Apr 2024 |
| Metronidazole Tablets IP 400 mg | MZTJ23002Mfg 2023-06 · Exp 2025-05 | DescriptionDescription | CDTL MumbaiCDSCO lab | Jan 2024 |
| Compound Benzoic Acid Ointment IP - 15g (Whitfield's Ointment) | B21027Mfg 2021-12 · Exp 2023-11 | Assay of Benzoic AcidAssay | CDL KolkataCDSCO lab | Nov 2023 |
| Ceftriaxone Injection IP 1g | CFI23016Mfg 2023-02 · Exp 2025-01 | Clarity of solutionOther | CDL KolkataCDSCO lab | Nov 2023 |
| Norfloxacin Tablets IP 400 mg | NRT23002Mfg 2023-01 · Exp 2024-12 | TEST FOR DISSOLUTI ONOther | CDTL ChennaiCDSCO lab | Sep 2023 |
| Norfloxacin Tablets IP 400 mg | NRT22009Mfg 2022-12 · Exp 2024-11 | TEST FOR DISSOLUTI ONOther | CDTL ChennaiCDSCO lab | Sep 2023 |
| Norfloxacin Tablets IP 400 mg | NRT2300 9Mfg 2023-01 · Exp 2024-12 | DISSOLUTIONDissolution | CDTL ChennaiCDSCO lab | Jul 2023 |
| Ciprofloxacin Tablets IP 500 mg | CPT22006Mfg 2022-05 · Exp 2024-04 | DissolutionDissolution | CDTL ChennaiCDSCO lab | Nov 2022 |
| Ciprofloxacin Tablets IP 500 mg | CPT22006Mfg 2022-05 · Exp 2024-04 | Test for DissolutionDissolution | CDTL ChennaiCDSCO lab | Sep 2022 |
| Iron Sucrose Injection U.S.P. 5 ml | ISI21019Mfg 2021-05 · Exp 2023-04 | Particulate MatterParticulate matter | CDL KolkataCDSCO lab | Aug 2022 |
| Ciprofloxacin Tablets IP 500 mg | CPT22004Mfg 2022-05 · Exp 2024-04 | DissolutionDissolution | CDTL ChennaiCDSCO lab | Aug 2022 |
| ATENOLOL Tablets IP 50mg | ATTJ21001Mfg 2021-01 · Exp 2022-12 | Disintegration and AssayAssay | RDTL GuwahatiState lab | May 2022 |
| Misoprostol Tablets I.P. 200mcg | MOT20002Mfg 2020-06 · Exp 2022-05 | AssayAssay | RDTL GuwahatiState lab | Apr 2022 |
| Ibuprofen Tablets IP 400 mg | BPT20003Mfg 2020-09 · Exp 2022-08 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2022 |
| Ibuprofen Tablets I.P. 400 mg | BPT20005Mfg 2020-09 · Exp 2022-08 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2022 |
| Atenolol Tablets IP 50 mg | ATTJ19006Mfg 2019-10 · Exp 2021-09 | DisintegrationDisintegration | RDTL GuwahatiState lab | Sep 2021 |
| Atenolol Tablets IP 50 mg | ATTJ21001Mfg 2021-01 · Exp 2022-12 | Disintegration & AssayAssay | RDTL GuwahatiState lab | Sep 2021 |
| Ciprofloxacin Tablets IP 500 mg | CPT20005Mfg 2020-06 · Exp 2022-05 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2021 |
| Atenolol Tablets IP 50 mg | ATTJ20002Mfg 2020-04 · Exp 2022-03 | DisintegrationDisintegration | RDTL GuwahatiState lab | Aug 2021 |
| Atenolol Tablets I.P. 50 mg. | ATTJ20002Mfg 2020-04 · Exp 2022-03 | DisintegrationDisintegration | RDTL GuwahatiCDSCO lab | Aug 2021 |
| Albendazole Tablets I.P.400mg | ABT18036Mfg 2018-08 · Exp 2020-07 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2020 |
| Albendazole Tablets I.P. 400 mg | ABT18032Mfg 2018-08 · Exp 2020-07 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2019 |
| Diclofenac Gel B.P. | D8173Mfg 2018-07 · Exp 2020-07 | AssayAssay | CDL KolkataCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.